Adrenergic supersensitivity in parkinsonians with orthostatic hypotension.

作者: J. M. SENARD , P. VALET , G. DURRIEU , M. BERLAN , M. A. TRAN

DOI: 10.1111/J.1365-2362.1990.TB01909.X

关键词: Blood pressureDiastolePlasma levelsEndocrinologyParkinson's diseasePlateletInternal medicineChemistryCatecholamineAdrenergicOrthostatic vital signs

摘要: . The adrenergic status was studied through evaluation of platelet α2-adrenoceptor number ([3H]-yohimbine binding sites), plasma catecholamine levels and blood pressure response to noradrenaline infusion in three groups subjects (1) Parkinsonians with orthostatic hypotension; (2) without (3) control subjects. In hypotension, systolic diastolic pressures significantly (P < 0.05) decreased from 144 pM 9 76 6 mmHg the lying position 95 12 60 7 after 5 min standing. these patients, were low (62 11 pg ml-1, when compared controls (219 13 ml-1) whereas no difference noticed hypotension (195 14 ml-1). dose required for a 25 increase 0.01) lower (019 0.03 μg kg-1) (0.86 0.11 or (0.68 0.l kg-1). Platelet x2-adrenoceptor higher (313 52 fmol mg-1 protein) than (168 (175 4 change Kd. This study demonstrates that patients Parkinson's disease, is associated an both vascular sensitivity number. These observations suggest existence α-adrenergic supersensitivity noradrenaline.

参考文章(24)
Michel Berlan, Olivier Rascol, Josine Belin, Jean-Pierre Moatti, André Rascol, Jean-Louis Montastruc, Alpha 2-adrenergic sensitivity in Parkinson's disease. Clinical Neuropharmacology. ,vol. 12, pp. 138- 144 ,(1989) , 10.1097/00002826-198904000-00010
G. Micieli, E. Martignoni, A. Cavallini, G. Sandrini, G. Nappi, Postprandial and orthostatic hypotension in Parkinson's disease Neurology. ,vol. 37, pp. 386- 386 ,(1987) , 10.1212/WNL.37.3.386
K Sakaguchi, R Hattori, Y Yui, Y Takatsu, T Susawa, N Yui, H Nonogi, S Tamaki, C Kawai, Altered platelet alpha 2 adrenoreceptor in acute myocardial infarction and its relation to plasma catecholamine concentrations. Heart. ,vol. 55, pp. 434- 438 ,(1986) , 10.1136/HRT.55.5.434
ALAIN VILLENEUVE, MICHEL BERLAN, MAX LAFONTAN, CLAUDINE CARANOBE, BERNARD BONEU, ANDRÉ RASCOL, JEAN-LOUIS MONTASTRUC, Platelet alpha2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatment European Journal of Clinical Investigation. ,vol. 15, pp. 403- 407 ,(1985) , 10.1111/J.1365-2362.1985.TB00292.X
R. J. Polinsky, I. J. Kopin, M. H. Ebert, V. Weise, Pharmacologic distinction of different orthostatic hypotension syndromes Neurology. ,vol. 31, pp. 1- 1 ,(1981) , 10.1212/WNL.31.1.1
J. G. McLeod, R. R. Tuck, Disorders of the autonomic nervous system: Part 1. Pathophysiology and clinical features Annals of Neurology. ,vol. 21, pp. 419- 430 ,(1987) , 10.1002/ANA.410210502
L. Orskov, J. Jakobsen, E. Dupont, B. de Fine Olivarius, N. J. Christensen, Autonomic function in parkinsonian patients relates to duration of disease Neurology. ,vol. 37, pp. 1173- 1173 ,(1987) , 10.1212/WNL.37.7.1173
J. Onrot, M. R. Goldberg, I. Biaggioni, R. G. Wiley, A. S. Hollister, D. Robertson, Oral yohimbine in human autonomic failure Neurology. ,vol. 37, pp. 215- 215 ,(1987) , 10.1212/WNL.37.2.215
P Valet, C Damase‐Michel, B Chamontin, D Durand, F Chollet, JL Montastruc, None, Platelet α2- and leucocyte β2-adrenoceptors in phaeochromocytoma: effect of tumour removal European Journal of Clinical Investigation. ,vol. 18, pp. 481- 485 ,(1988) , 10.1111/J.1365-2362.1988.TB01043.X